VIMPAT

1 stories · following the connections

Business

Adamas Pharmaceuticals Completes Phase 1 Clinical Trial of ADS-4101 for Treatment of Partial Onset Seizures in Patients with Epilepsy

By Nasdaq OMXJan 3, 2017, 9:53 PM UTC